Global Varicose Vein Treatment Market to Clock CAGR of ~5% From 2019 to 2027, Expanding Array of New Minimally-Invasive Techniques Key to Growth

Transparency Market Research

Constant launch of an array of new, novel minimally-invasive therapies has opened new avenues in the varicose vein treatment market. A case in point is endovenous cyanoacrylate super-glue

New techniques to develop safe and effective treatments to chronic venous insufficiency have helped expand market potential; sclerotherapy has attracted intense focus

ALBANY, New York, Feb. 25, 2020 /PRNewswire/ -- An array of devices, catheter techniques, and agents that promise less-invasive ways of treating or managing varicose veins is gaining acceptance among patients and surgeons. Advent of novel therapies and patient-friendly therapeutic interventions has expanded the revenue potential of the market, as envisaged by the analysts of a new study on the varicose veins treatment market.

The valuation of the global Varicose Vein Treatment Market stood at ~US$ 1.5 bn in 2018 and is expected to clock a CAGR of ~5% during the forecast period 2019–2027. Advancements in endothermal ablasion or endovenous laser treatment are broadening the scope of revenue generation for players in the market.

"Companies in the varicose vein treatment market should focus on developing compression bandages and other compression products with better clinical outcomes, such as speedy recovery," opine analysts at TMR. They further add, "Phlebectomy is a reliable surgical treatment that is less technically challenging as compared to many other treatment options. Companies should lean on introducing minimally-invasive devices that improve outcomes in patients"

Varicose Vein Treatment Market Study

• Of all the disease treated, greater saphenous varicose veins holds the leading share of the global revenues; rising at an exemplary growth, it is expected to reach worth of ~US$ 1 billion by 2024-end
• Among the various key treatment types, endovenous ablation accounted for a sizable share of revenues in the global varicose veins treatment market. The projected worth is ~US$ 800 million by 2027-end; it is considered as the first line of treatment of varicose veins. The sclerotherapy/adhesion injection segment held the leading share in the global market in 2018
• The dominant share of revenues is projected to come from compression garments and devices; the segment will reach valuation worth of ~US$ 1.1 billion by the end of 2027. Compression therapies have gained acceptance among patients to post the sclerotherapy
• The demand for ablation devices is expected to rise at rapid pace over the forecast period.

Explore 230 pages of top-notch research, incisive insights, and detailed country-level projections. Gain business intelligence on Varicose Vein Treatment Market (Treatment Type: Endovenous Ablation, Sclerotherapy/Adhesion Injections, Ligation/Stripping, Supportive Treatments; Product: Ablation Devices [Radio Frequency Ablation/Thermal Ablation, Laser Ablation Devices, Ultrasound Ablation Devices], Catheters/Kits for Sclerotherapy & Adhesion Injections, Compression Devices/Garments, Others; Disease: Greater Saphenous Varicose Vein, Small Saphenous Varicose Vein, Others; End User: Hospitals & Ambulatory Surgical Centers, Specialty Clinics, Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019 – 2027 at https://www.transparencymarketresearch.com/report-toc/11714